Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine, Metronidazole, and Combination Gels for Gingivitis
NCT03142607Phase 3Unknown
- Sponsor
- Aga Khan University
- Start
- Feb 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metronidazole in gingivitis (3 arms), sponsored by Aga Khan University. Primary endpoint: Change in Gingival Index at 4 weeks. Status: unknown.
02
Drugs
metronidazole
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT03142607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03142607.